A. Albert

发表

1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN

J. Reginster, P. Franchimont, M. Lecart, 1987, The Lancet.

A 5‐year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium

P. Franchimont, J. Reginster, R. Deroisy, 1994, European journal of clinical investigation.

Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis.

J. Reginster, D. de Groote, N. Franchimont, 1997, Maturitas.

Long-term performance in vitro and in vivo of dual-energy X-ray absorptiometry

J. Reginster, P. Franchimont, B. Zegels, 1995, Clinical Rheumatology.

Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits

J. Reginster, P. Franchimont, N. Franchimont, 1992, Calcified Tissue International.

Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50.

J. Reginster, B. Vrijens, P. Franchimont, 1997, Maturitas.

Minimal levels of serum estradiol prevent postmenopausal bone loss

J. Reginster, P. Franchimont, N. Sarlet, 1992, Calcified Tissue International.

Parathyroid hormone plasma concentrations in response to low 25-OH vitamin D circulating levels increases with age in elderly women.

J. Reginster, W. Dewé, A. Taquet, 1998, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

Administration of a supplement containing both calcium and vitamin D is more effective than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25(OH)vitamin D circulating levels

J. Reginster, J. Collette, R. Deroisy, 2002, Aging clinical and experimental research.

Prediction of Bone Loss Rate in Healthy Postmenopausal Women

J. Reginster, B. Zegels, J. Collette, 1997, Calcified Tissue International.

Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers

J. Reginster, R. Deroisy, A. Albert, 1997, Clinical Rheumatology.

Comparison of the short-term effects of three oral calcium-vitamin D formulations and placebo on calcium metabolism

J. Reginster, J. Collette, R. Deroisy, 1998 .

Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion

J. Reginster, B. Zegels, A. Taquet, 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

One year's treatment of paget's disease of bone by synthetic salmon calcitonin as a nasal spray

J. Reginster, P. Franchimont, J. Reginster, 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Influence of the nature of calcium salts on serum calcium, phosphorus, calcitonin, growth hormone, and somatomedin C

J. Reginster, P. Franchimont, G. Heynen, 1988, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Sepsis and serum cytokine concentrations.

M. Lamy, A. Albert, P. Damas, 1997, Critical care medicine.

Dual photon absorptiometry of lumbar spine in West European (Belgian) postmenopausal females: normal range and fracture threshold

J. Reginster, P. Franchimont, J. Collette, 1990, Clinical Rheumatology.

Bone mineral density of the spine and the hip measured with dual energy X-ray absorptiometry: Normal range and fracture threshold for Western European (Belgian) postmenopausal females

J. Reginster, P. Franchimont, B. Zegels, 2005, Clinical Rheumatology.

Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects.

J. Reginster, P. Franchimont, A. Albert, 1987, Bone and mineral.

CALCITONIN AND POSTMENOPAUSAL BONE LOSS

J. Reginster, P. Franchimont, M. Lecart, 1990, Experimental Gerontology.

Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics.

J. Reginster, P. Franchimont, J. Collette, 1989, The Journal of clinical investigation.